Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Numan Alabdan
Observed names:
Alabdan, Numan,
Numan A Alabdan,
Numan A. AlAbdan,
Numan A. Alabdan,
Numan Abdulraman Alabdan
Institutions:
King Saud bin Abdulaziz University for Health Sciences,
King Abdulaziz Medical City,
King Abdullah International Medical Research Center,
National Guard Health Affairs
Observed institutions:
University of Tennessee Health Science Center,
King Saud bin Abdulaziz University for Health Sciences,
King Abdulaziz Medical City,
King Abdullah International Medical Research Center,
National Guard Health Affairs
ORCID:
0000-0003-0546-4720
Observed ORCID:
0000-0003-0546-4720
OpenAlex ID:
A5086589247
Comparison of initial warfarin response in obese patients versus non-obese patients
2012
·
Jessica L. Wallace
, Anne B. Reaves
, et al.
·
Journal of Thrombosis and Thrombolysis
·
96
Evaluation of Warfarin Dose Requirements in Patients with Chronic Kidney Disease and End‐Stage Renal Disease
2014
·
Sami A. Sakaan
, Joanna Q. Hudson
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
22
Fasting during Ramadan and acute kidney injury (AKI): a retrospective, propensity matched cohort study
2022
·
Numan A. AlAbdan
, Omar A. Almohammed
, et al.
·
BMC Nephrology
·
18
PDF
Acute Kidney Injury in Patients Continued on Renin-Angiotensin System Blockers During Hospitalization
2016
·
Numan Alabdan
, Elvira O. Gosmanova
, et al.
·
The American Journal of the Medical Sciences
·
13
Awareness of acute kidney injury risk factors and perspectives on its practice guidelines
2018
·
Numan Alabdan
, Abdelhameed H. Elfadol
, et al.
·
Hospital Practice
·
8
The Utilization of Spironolactone in Heart Failure Patients at a Tertiary Hospital in Saudi Arabia
2020
·
Abdulmalik S Alotaibi
, Numan Alabdan
, et al.
·
Cureus
·
7
PDF
The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective study
2022
·
Khalid Al Sulaiman
, Ohoud Aljuhani
, et al.
·
Saudi Pharmaceutical Journal
·
6
PDF
Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study
2025
·
Yazed AlRuthia
, Khlood Khaled Almutairi
, et al.
·
Healthcare
·
4
PDF
An exploration of factors influencing the selection of generic and innovator medicines in Saudi Arabia using an observational cross-sectional study
2024
·
Othman AlOmeir
, Mansour Almuqbil
, et al.
·
Saudi Pharmaceutical Journal
·
4
Transforming Healthcare: A Scoping Review of the Significance of Value-Based Healthcare
2025
·
Hind Almodaimegh
, Laila Carolina Abu Esba
, et al.
·
Global Journal on Quality and Safety in Healthcare
·
3
PDF
Validity and reliability of the Arabic-translated kidney disease quality of life survey among long-term dialysis patients in Saudi Arabia.
2021
·
Numan A Alabdan
, Abdulla A Al-Sayyari
, et al.
·
PubMed
·
3
Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function
2024
·
Maram A. Alzahrani
, Numan A. AlAbdan
, et al.
·
Journal of Clinical Medicine
·
2
PDF
The impact of child-specific characteristics on warfarin dosing requirements
2024
·
Yousif S. Alakeel
, Abdulraouf M.Z. Jijeh
, et al.
·
Research and Practice in Thrombosis and Haemostasis
·
2
PDF
Predictors of adherence to a new erythropoiesis-stimulating agent inpatient ordering policy: A cross-sectional study
2017
·
Numan Alabdan
, Yazed AlRuthia
, et al.
·
PLoS ONE
·
1
PDF
Procedures for Pricing Medication and the Impact of Management Entry Agreement on the Pricing and Negotiation
2025
·
Hind Almodaimegh
, Laila Carolina Abu Esba
, et al.
·
Saudi Journal of Clinical Pharmacy
Awareness of acute kidney injury risk factors and perspectives on its practice guidelines
2018
·
Alabdan, Numan
, Abdelhameed H. Elfadol
, et al.
·
Figshare
Show more works
View as search
Works count:
16
Citation count:
189
H-index:
6
I10-index:
4
Year
Topic
Type